In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $4.65 in the prior trading day, Radiopharm Theranostics Ltd ADR (NASDAQ: RADX) closed at $4.03, down -13.33%. In other words, the price has decreased by -$13.33 from its previous closing price. On the day, 59241.0 shares were traded. RADX stock price reached its highest trading level at $4.41 during the session, while it also had its lowest trading level at $3.71.
Ratios:
Our goal is to gain a better understanding of RADX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RADX now has a Market Capitalization of 8868620288 and an Enterprise Value of 8737687552. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.93 while its Price-to-Book (P/B) ratio in mrq is 100.75. Its current Enterprise Value per Revenue stands at 4461.361 whereas that against EBITDA is -271.34.
Stock Price History:
Over the past 52 weeks, RADX has reached a high of $50.82, while it has fallen to a 52-week low of $3.55. The 50-Day Moving Average of the stock is -34.17%, while the 200-Day Moving Average is calculated to be -34.17%.
Shares Statistics:
The stock has traded on average 64.41K shares per day over the past 3-months and 69930 shares per day over the last 10 days, according to various share statistics. Insiders hold about 12.00% of the company’s shares, while institutions hold 10.70% stake in the company.
